Back to search
FDAFDA · Food and drugs·Recall number D-0632-2022

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-192-07.

Published March 9, 2022 · Recall initiated: February 15, 2022

Summary

FDA records drug Class II recall D-0632-2022, published March 9, 2022 and initiated February 15, 2022. Recalling firm: Macleods Pharma Usa Inc; Status: Terminated; Reported quantity: 3,672 bottles; Lot: Lot#: BAD62101A, Exp 2/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations

What to do

Voluntary: Firm initiated · Letter

Get an email if AMLODIPINE AND OLMESARTAN MEDOXOMIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMLODIPINE AND OLMESARTAN MEDOXOMIL
Manufacturer
Macleods Pharma Usa Inc
Distributor
USA Nationwide
UPC
0333342192073
Lot
Lot#: BAD62101A, Exp 2/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-192-07. recalled?

Yes. FDA published recall D-0632-2022 on March 9, 2022. Reported hazard: cGMP deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMLODIPINE AND OLMESARTAN MEDOXOMIL. UPC: 0333342192073.